Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06293482 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

A NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral, sponsored by Cochlear.

Active
Registry status
NA
Development phase
50
Enrollment target
9
Study locations

NCT06293482 is a NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral that is active but no longer recruiting, run by Cochlear. The registered enrollment target is 50 participants, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06293482, a NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral, is active but no longer recruiting, sponsored by Cochlear.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
9
Study locations

Study Summary

This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessments and questionnaires over the course of seven visits.

Conditions Studied

Hearing Loss, Sensorineural Hearing Loss, Bilateral

Interventions

  • DEVICE Cochlear™ Nucleus® System

Study Locations (9)

Arizona

  • Barrow Neurological Institute - Phoenix
  • Centre for Neurosciences - Tucson

California

  • Pacific Neuroscience Institute - Santa Monica

Florida

  • University of Miami - Coral Gables

Indiana

  • Indiana University - Indianapolis

Missouri

  • Midwest Ear Institute - Kansas City

New York

  • New York University - New York

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • University of Pennsylvania Hospitals - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-17
Est. Completion 2028-10
Phase NA

Sponsor

Cochlear

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06293482

The ClinicalTrials.gov registry entry for NCT06293482 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Cochlear™ Nucleus® System is the first listed.

NCT06293482 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Arizona, California, Florida.

Frequently Asked Questions

What is clinical trial NCT06293482 about?

NCT06293482 is a clinical study titled "Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population". This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessment...

What is the current status of trial NCT06293482?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-17. Estimated completion is 2028-10.

What conditions does trial NCT06293482 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Hearing Loss, Bilateral.

What interventions are being tested in trial NCT06293482?

The interventions under investigation include: Cochlear™ Nucleus® System (DEVICE).

Who is sponsoring clinical trial NCT06293482?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06293482 being conducted?

This trial has 9 study locations across Arizona, California, Florida, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hearing Loss, Sensorineural

All registered trials for this condition

Hearing Loss, Bilateral

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.